Embolic protection devices are devices used to prevent or reduce plaque debris from reaching the distal bed during surgical procedures. They are commonly used in Saphenous Vein Graft (SVG) interventions and during carotid artery stenting procedures.
Embolic Protection Devices Market Rise with Increasing prevalence of rate in cardiovascular disorders is likely to drive the growth of the global market at a CAGR of 8.5% during 2018 to 2023
The global embolic protection devices market is majorly driven by the high prevalence of cardiovascular diseases, increasing technical advanced devices, increasing demand for minimally invasive procedures, and growing penetration by market players.
Request for an Free Sample at https://www.marketresearchfuture.com/sample_request/5978
Embolic Protection Devices Market Segmentation
The global embolic protection devices market is segmented on the basis of type, material, usage, application, and end-user.
On the basis of type, the market is segmented into distal filter devices, distal occlusion devices, and proximal occlusion devices.
On the basis of material, the market is segmented into nitinol and polyurethane.
On the basis of usage, the market is segmented into disposable devices and reusable devices.
On the basis of application, the market is segmented into cardiovascular diseases, neurovascular diseases, and peripheral vascular diseases.
On the basis of cardiovascular diseases, it is further sub-segmented into coronary artery diseases, trans Cather aortic valve replacement, and saphenous vein graft diseases.
On the basis of the end-user, the market is segmented into hospitals and clinics, specialty centers, and ambulatory surgical centers.
Embolic Protection Devices Market Players
Some of the key players in the Embolic Protection Devices market are Medtronic, Abbott, Boston Scientific, Cordis, Contego Medical, W. L. Gore & Associates, Claret Medical, Allium Medical Solutions, and Angioslide.
13 Company Profiles
13.1.1 Company Overview
13.1.2 Product Overview
13.1.4 SWOT Analysis
13.2 Abbott Laboratories
13.2.1 Company Overview
13.2.2 Product Overview
13.2.3 Financial Overview
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.3 Boston Scientific
13.3.1 Company Overview
13.3.2 Product Overview
13.3.3 Financial Overview
13.3.4 Key Development
13.3.5 SWOT Analysis
13.4.1 Company Overview
13.4.2 Product/Business Segment Overview
Access Complete Premium Research Report at https://www.marketresearchfuture.com/reports/embolic-protection-devices-market-5978
The Americas dominates the global embolic protection devices market owing to the increasing aging population, which eventually leads to the increasing patient population. According to the American Heart Association, 31% of the deaths in the U.S. were due to cardiovascular disorders. Similarly, according to the Center for Disease Control and Prevention, in 2015, around USD 3.2 trillion were spend in healthcare expenditure in the U.S.
Europe accounts for the second largest market due to the increasing cardiovascular disorders and increasing obesity rates. Additionally, the increasing government support and increasing healthcare infrastructure along with the rising demand for minimally invasive treatment are driving the growth of the embolic protection devices market in Europe. For instance, Eurostat estimated that over 19.2% of the population in Europe were aged 65 and above.
Asia Pacific is the fastest growing market for the embolic protection devices whose growth is attributed to rising population and increasing standard of living. India and China are the major contributors to the market growth due to the rapid development of healthcare infrastructure in these regions and increasing demand for diagnostic services.
On the other hand, the Middle East and Africa is expected to witness a slow growth due to limited access to healthcare and affordability issues among the population. In the Middle East, the growth of the market is driven by the increasing availability of new and advanced diagnostic and treatment methods for various chronic diseases.
Get for an Amazing Discount at https://www.marketresearchfuture.com/check-discount/5978
- Pharmaceutical Manufacturers and Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investor
About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312